News and Trends 22 Dec 2022
Japanese companies look to reduce environmental impact
Japanese companies Astellas Pharma Inc., Eisai Co., Ltd., Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical Company Limited have agreed a…
Takeda
- Latest Posts
News and Trends 8 Apr 2020
Evotec Makes Move into Gene Therapy with Takeda Deal
German biotech giant Evotec has moved into gene therapy and partnered with Takeda to develop new therapies in oncology, rare…
News and Trends 31 Oct 2019
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to discover biomarkers that can predict…
News and Trends 16 Oct 2019
GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech
The UK biotech GammaDelta Therapeutics has founded Adaptate Biotherapeutics to develop cancer immunotherapies based on antibodies that boost a rare…
ADVERTISEMENT
News and Trends 5 Jan 2018
Takeda Starts the Year Bidding for a Belgian Stem Cell Therapy Biotech
Takeda has offered to acquire TiGenix subject to the upcoming European approval of its lead stem cell therapy for Crohn's…
News and Trends 15 Jun 2017
Where to Find the Perfect Mix of International and German Biotechs? Berlin!
Germany's capital city Berlin is the perfect meeting place for international and German biotech companies. See here why the city has…
More News! 9 May 2017
British Biotech Startup Partners with Takeda to Advance its T Cell Platform
GammaDelta Therapeutics and Takeda have formed a strategic collaboration to develop a novel T cell platform, which is based on…
News and Trends 11 Oct 2016
UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies
Crescendo Biologics, a small UK-based startup, has made an almost €1B deal with Japanese giant Takeda for its Humabody technology. …
News and Trends 6 Jul 2016
Takeda snatches up Belgian Cell therapy for Crohn’s Disease
TiGenix is licensing the rights for its cell therapy which is under EMA review and is meant to treat a…
News and Trends 25 Jan 2016
Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease
What updates have occurred in the Neurodegenerative disease field as of late? New appointments by the Dementia Discovery Fund, which…
News and Trends 26 Nov 2015
The UK-Israeli €378M Small-Molecule Offensive Against Migraines
The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up on novel drug therapies targeting…
News and Trends 27 Oct 2015
Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries
The Belgian biomanufacturing company Univercells and the Japanese pharmaceutical company Takeda have signed a strategic partnership agreement. Univercells has closed a…
News and Trends 30 Mar 2015
#BioFigures: €406 Million Antibody-drug conjugate Deal struck by ImmunoGen andTakeda
WHO? ImmunoGen is a biotechnology company that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate (ADC) technology. The Company's uses…
